Fundraising Fox

Dylan Hartley

Executive at Onkure Therapeutics Inc

Boulder, Colorado, United States

Find your path to Dylan

17 people in our graph share verified history with Dylan — schools, employers, funds. One of them is your warm intro.

Larry BurgessunlockedDylan: together at Arraybiopharma (2005–2018)
×3Dylan: together at Arraybiopharma
×4Dylan: together at University of Colorado Anschutz
×2Dylan: together at Onkure Therapeutics Inc

Executive at Onkure Therapeutics Inc

Intro paths

→

In turn, Dylan can intro founders to Onkure Therapeutics Inc's investors below.

Onkure Therapeutics Inc's investors · 7

AbingworthLondon · $15M – $30M checks · since 2020Access BiotechnologyNew York CityACORN BIOVENTURESNew York · since 2024Boulder VenturesBoulder · $1M – $4M checksNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024Novo HoldingsCopenhagen · $1.1M – $54M checksRiverVest Venture PartnersSt. Louis · $500K – $3M checks

Experience

  1. OnKure TherapeuticsChief Scientific Officercurrent2024 — present
  2. PfizerVice President, Head of Research at Pfizer Boulder R&D2021 — 2024Boulder, Colorado, United States
  3. PfizerVice President DMPK and Discovery Technologies2021Boulder, Colorado, United States
  4. PfizerExecutive Director2019 — 2021Boulder Research and Development Unit
  5. Array BioPharma Inc.Senior Director, Drug Metabolism and Pharmacokinetics, Ph.D., DABT2018 — 2019Boulder, CO
  6. Array BioPharmaDirector, Drug Metabolism and Pharmacokinetics2013 — 2018Boulder, CO
  7. Array BioPharmaAssociate Director, Drug Metabolism and Pharmacokinetics2011 — 2013Boulder, CO
  8. GenentechSenior Scientist: Investigative Safety Assessment2009 — 2011
  9. Array BiopharmaSenior Research Investigator2008 — 2009
  10. Array BiopharmaResearch Investigator2005 — 2008
  11. MerckResearch Fellow2004 — 2005
  12. MerckSenior Research Chemist2001 — 2004
  13. University of Kansas Medical CenterResearch Assistant Professor1999 — 2001

Skills & more

Clinical TrialsNeuroscienceChemistryResearch and Development (R&D)Resource ManagementValue CreationPre-clinical StudiesCell BiologyLearningOncologyClinical StrategyCompensation & Benefits
+12 moreClinical DataPrecision MedicineTherapeutic AreasBiotechnologyDrug MetabolismIn VitroADMEDrug DevelopmentToxicologyDrug DiscoveryPharmacokineticsIn Vivo

From Dylan's professional profile.

Frequently asked questions

Who is Dylan Hartley?
Executive Officer at Onkure Therapeutics Inc
Where does Dylan Hartley work?
Dylan Hartley is Executive at Onkure Therapeutics Inc.
Where did Dylan Hartley go to school?
Dylan Hartley studied at University of Colorado Anschutz (Ph.D., Toxicology and Pharmaceutical Sciences); University of Kansas Medical Center (Post-Doctoral Studies, Toxicology Fellow).

Same school

Also attended University of Colorado Anschutz7

Jonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesDevin LeakeManaging Director at Novalis LifeSciencesBeth LandryExecutive Partner at NaviMed CapitalAsha NayakInvestor at Johnson & Johnson Innovation – JJDCKrishna PoluPrincipal at Red Tree VentureBalaji SridharExecutive Officer, Director at Nanoly Bioscience

+ 1 more

Also attended University of Kansas Medical Center1

Sida NiuCo-founder & Chief Medical Officer at Docology

Shared employers

Also worked at Pfizer288

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital

+ 282 more

Also worked at Array BioPharma Inc.6

Steve TregayManaging General Partner at Mission BiocapitalLarry BurgessExecutives in Residence at GENERAL INCEPTIONKyle LefkoffGeneral Partner at Boulder VenturesJohn JoseyPartner at The Column GroupJoey MoneyLife Sciences Client Manager at Innosphere VenturesKevin KochExecutive Officer, Director at Edgewise Therapeutics

Also worked at Genentech204

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 198 more

Also worked at Merck181

Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures

+ 175 more